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Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance
in Salmonella enterica serovar Typhimurium
Abstract
Bacterial heteroresistance has been identified in several combinations of bacteria and antibiotics, and it
complicated the therapeutic strategies. Tigecycline is being used as one of the optimal options for the
treatment of infections caused by multidrug-resistant Salmonella. This study investigated whether
heterorresistance to tigecycline exists in a Salmonella enterica serovar Typhimurium strain harboring the
oqxAB-bearing IncHI2 plasmid pHXY0908. MIC and population analyses were performed to evaluate
population-wide susceptibility to tigecycline. The effects of efflux pumps on MIC levels were assessed using
the efflux pump inhibitor Phe-Arg-β-naphthylamide, measuring intracellular tigecycline accumulation as well
as mRNA levels of regulatory and efflux pump genes. DNA sequencing of regulatory regions were performed
and plasmid curing from a resistant strain provided an appropriate control. Results showed that MICs of a
parental strain with and without pHXY0908 as well as a plasmid-cured strain 14028/Δp52 were 0.5, 1, and 1
μg/mL, respectively. Population analysis profiling (PAP) illustrated that only the pHXY0908-containg strain
was heteroresistant to tigecycline. A fraction of colonies exhibited stable profiles with 4- to 8-fold increases in
MIC. The frequencies of emergence of these isolates were higher in the plasmid-containing strain pHXY0908
than either the parental or the 14028/Δp52 strain. Phe-Arg-β-naphthylamide addition restored tigecycline
susceptibility of these isolates and intracellular tigecycline accumulation was reduced. Heteroresistant isolates
of the strain containing pHXY0908 also had elevated expression of acrB, ramA, and oqxB. DNA sequencing
identified numerous mutations in RamR that have been shown to lead to ramA overexpression. In
conclusions, heteroresistance to tigecycline in Salmonella enterica serovar Typhimurium was manifested in a
plasmid-bearing strain. Our results suggest that this phenotype was associated with overexpression of the
AcrAB-TolC and OqxAB efflux pumps.
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Bacterial heteroresistance has been identified in several combinations of bacteria and
antibiotics, and it complicated the therapeutic strategies. Tigecycline is being used
as one of the optimal options for the treatment of infections caused by multidrug-
resistant Salmonella. This study investigated whether heterorresistance to tigecycline
exists in a Salmonella enterica serovar Typhimurium strain harboring the oqxAB-bearing
IncHI2 plasmid pHXY0908. MIC and population analyses were performed to evaluate
population-wide susceptibility to tigecycline. The effects of efflux pumps on MIC levels
were assessed using the efflux pump inhibitor Phe-Arg-β-naphthylamide, measuring
intracellular tigecycline accumulation as well as mRNA levels of regulatory and efflux
pump genes. DNA sequencing of regulatory regions were performed and plasmid curing
from a resistant strain provided an appropriate control. Results showed that MICs
of a parental strain with and without pHXY0908 as well as a plasmid-cured strain
14028/1p52 were 0.5, 1, and 1 µg/mL, respectively. Population analysis profiling (PAP)
illustrated that only the pHXY0908-containg strain was heteroresistant to tigecycline.
A fraction of colonies exhibited stable profiles with 4- to 8-fold increases in MIC. The
frequencies of emergence of these isolates were higher in the plasmid-containing strain
pHXY0908 than either the parental or the 14028/1p52 strain. Phe-Arg-β-naphthylamide
addition restored tigecycline susceptibility of these isolates and intracellular tigecycline
accumulation was reduced. Heteroresistant isolates of the strain containing pHXY0908
also had elevated expression of acrB, ramA, and oqxB. DNA sequencing identified
numerous mutations in RamR that have been shown to lead to ramA overexpression. In
conclusions, heteroresistance to tigecycline in Salmonella enterica serovar Typhimurium
was manifested in a plasmid-bearing strain. Our results suggest that this phenotype was
associated with overexpression of the AcrAB-TolC and OqxAB efflux pumps.
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INTRODUCTION
Salmonella enterica serovar Typhimurium is an important
zoonotic pathogen that leads to various infections in
humans and the proliferation of multidrug-resistant isolates,
especially those extended-spectrum β-lactamase-producing and
fluoroquinolone-resistant strains are of major concerns (Fàbrega
et al., 2008). Carbapenems and colistin were therapeutic options
for treatment of severe infections caused by multidrug-resistant
bacteria such as the Typhimurium serovar (Taneja and Kaur,
2016). However, the emergence of carbapenemase-producing
and mcr-1-positive Salmonella has threatened the treatment
options (Liu et al., 2016; Yao et al., 2016).
Tigecycline represents a new class of antibiotic agents, the
glycylcyclines. This compound exhibits an extraordinarily
broad-spectrum of activity against pathogens, including
difficult-to-treat pathogens such as carbapenemase- or
extended-spectrum β-lactamases-producing Gram-negative
bacteria (Stein and Babinchak, 2013). Antimicrobial activity of
tigecycline results from a stacking interaction with nucleobase
C1054 within the decoding site of the ribosome and during
decoding, tigecycline inhibits the initial codon recognition step
of tRNA accommodation (Jenner et al., 2013). Tigecycline is
readily transported into the cell and achieves high intracellular
concentrations (Ong et al., 2005). This is a key factor when
considering treatment of invasive infections caused by
multidrug-resistant Salmonella (Tang et al., 2016).
Although tigecycline bypasses the classical resistance
mechanisms that confer resistance to tetracyclines (Fluit et al.,
2005), the compound is still vulnerable to chromosomally
encoded eﬄux pumps (Keeney et al., 2007, 2008; Ruzin et al.,
2007). Up-regulation of multidrug eﬄux pumps such as AcrAB
in Escherichia coli (Keeney et al., 2008), Klebsiella pneumonia
(Zhong et al., 2014), and Enterobacter cloacae (Keeney et al.,
2007); AdeABC in Acinetobacter baumanni (Ruzin et al., 2007),
and MexXY in Pseudomonas aeruginosa (Dean et al., 2003)
have all been implicated in tigecycline resistance. An RND
family eﬄux pump, OqxAB may also supplement tigecycline
resistance in K. pneumonia (Zhong et al., 2014) and E. cloacae
(Veleba et al., 2013). The AcrAB-TolC eﬄux pump transports
numerous structurally unrelated compounds (Du et al., 2014).
Its expression is modulated precisely by its local repressor, AcrR,
as well as by global transcriptional regulators of the AraC family,
RamA, MarA, SoxS, and Rob (Nikaido et al., 2008; Kehrenberg
et al., 2009; Pérez et al., 2012). Mutations in acrR cause the loss
of its repressor function, resulting in acrAB overexpression. In
addition, mutations in ramR, marR, and soxR activate ramA,
marA, and soxS, leading to the upregulation of the acrAB eﬄux
pump.
Heteroresistance is the presence of a subpopulation of less
susceptible bacteria in a population of fully susceptible bacteria
(El-Halfawy and Valvano, 2015). This phenomenon was first
described in Staphylococcus aureus in 1970 (El-Halfawy and
Valvano, 2015) and has been widely investigated. Distinct
from the persistence which was linked to phenotypic switching
between growing cells and persister cells having reduced growth
rates and cells regrown from them remain sensitive to the
antibiotic (Balaban et al., 2004), heteroresistance means the
coexistence of resistant and susceptible bacterial cells in the same
culture (El-Halfawy and Valvano, 2015). Population analysis
profiling (PAP) is the conventional method for determining
heteroresistance (El-Halfawy and Valvano, 2015). Bacterial
antibiotic resistance can be either intrinsic or acquired and
these are equally applicable to heteroresistance (El-Halfawy and
Valvano, 2015). Heteroresistance can also be an intermediate
stage for completely changing from susceptibility to resistance
upon exposure of bacteria to an antibiotic (Morand and
Mühlemann, 2007; Falagas et al., 2008).
Clinical isolates of Salmonella resistant to tigecycline have
now been reported (Hentschke et al., 2010). Non-typhoidal
Salmonella has a wide host specificity and global burden
compared to typhoidal Salmonella (Smith et al., 2016). Up to
this point, there have been no investigations on tigecycline
heteroresistance in Salmonella enterica serovar Typhimurium.
Thus the main purpose of this study was to investigate
whether heteroresistance to tigecycline exists in Salmonella
enterica serovar Typhimurium 14028 and 14028/pHXY0908
(14028 harboring oqxAB-bearing IncHI2 plasmid pHXY0908)
and to determine molecular mechanisms responsible for
tigecycline heteroresistance. 14028/pHXY0908 was obtained by
electroporation of a transferable IncHI2-type plasmid pHXY0908
(KM877269) carrying the quinolone resistance determinate
oqxAB from S. Typhimurium-147 into Salmonella enterica
serovar Typhimurium 14028. The multidrug-resistant IncHI2
plasmid pHXY0908 (GenBank accession number KM877269)
from S. Typhimurium has been involved in the spread of oqxAB
in food-producing animals in China (Li et al., 2013).
MATERIALS AND METHODS
Strains and Antibiotic Susceptibility Testing
The bacterial strains and plasmids used in this study are listed
in Table 1. Typhimurium strains were routinely propagated in
Mueller-Hinton (MH) or Luria-Bertani (LB) medium. The MIC
of tigecycline was determined by standard broth microdilution
methods according recommendations of the Clinical and
Laboratory Standards Institute (M100-S25). All media were
freshly prepared (<12 h) in order to minimize the oxidative
degradation of tigecycline (Hope et al., 2005). The breakpoint
criteria used to determine tigecycline phenotype was based on the
United States Food and Drug Administration breakpoint criteria
[≤ 2 mg/L (susceptibility), 4 mg/L (intermediate), and ≥ 8 mg/L
(resistance)]. E. coli ATCC 25922 was included and used as a
reference strain.
Population Analysis Profiling (PAP)
PAP was conducted as previously described (Hung et al., 2012).
Briefly, 40 µL of overnight culture was subcultured in 4 mL
of LB broth, and grown to late logarithmic phase (OD600 =
0.3–0.4). Dilutions of 10−2–10−6 in 0.85% saline were prepared,
and 100 µL (∼108 bacterial CFU) was spread onto MH agar
plates containing tigecycline in serial dilutions at concentrations
ranging from 0.125 to 16 µg/mL (0.5 to 16 × MIC). A dilution
of 10−6 was deposited onto MH plates lacking antibiotic for
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TABLE 1 | Strains and plasmid used in this study.
Strain or plasmid Description
S. TYPHIMURIUM
14028 ATCC 14028
14028#2 Derived from 14028 with ramR mutation
14028#3 Derived from 14028 with ramR mutation
14028/pHXY0908 Derivative of 14028 harboring plasmid pHXY0908
14028/p#36 Heteroresistant isolate of 14028/pHXY0908 with ramR
mutation
14028/p#52 Heteroresistant isolate of 14028/pHXY0908 with ramR
mutation
14028/1p52 Plasmid-cured strain of 14028/p#52
14028/1p52#17 Resistant isolate of 14028/1p52
14028/1p52#18 Resistant isolate of 14028/1p52
Plasmid
pHXY0908 An IncHI2-type plasmid containing oqxAB, sul, aphA1,
aadA1, cmlA, aadA2, floR, aac(3′)-IV, aac(6′)-Ib-cr,
blaOXA−1, catB3, qacEdelta1 (GenBank accession
number KM877269)
determination of colony number after 48 h at 37◦C. The
frequency of appearance of heteroresistant subpopulations was
calculated by dividing the number of colonies that grew on
antibiotic-containing plates (4–16 × MIC) by the number that
grew on antibiotic-free plates (Morand and Mühlemann, 2007).
The analysis was performed three times and the mean values
of viable CFU were calculated and plotted on a semilogarithmic
graph.
Luria-Delbrück Fluctuation Analysis and
Stability of Resistance Profiles
To investigate whether the resistant subpopulations were derived
from pre-adapted antibiotic-resistant cells that initially existed in
the culture, Luria-Delbrück fluctuation analysis was performed
as previously described (Sánchez-Romero and Casadesus, 2014).
Briefly, a small number of cells were used to inoculate parallel
tubes containing LB broth and were then grown to saturation to
obtain equal cell densities. One hundred microliters of overnight
samples (∼2 × 108 cells) from individual subcultures were
separately plated onto LB agar plates containing tigecycline at
concentrations of 5 × MIC or 2.5 × MIC. Simultaneously,
samples containing the same amount of bacteria from single
bacterial cultures were plated onto parallel plates lacking
antibiotic. Colonies were counted after 48 h incubation. The
concentration of tigecycline was selected to suppress sensitive
cells in bacterial cultures and allow the growth of subpopulations
containing high-level resistance that was judged by the results of
MIC and PAP testing.
Survivors picked up from the drug-containing plates were
determined susceptibility to tigecycline by an agar dilution
method according to CLSI recommendation M100-S25. After
seven daily subcultures in antibiotic-free medium, the tigecycline
MICs were re-tested to check the stability of the resistant
phenotypes. To determine whether eﬄux activity was responsible
for reduced susceptibility to tigecycline, 2-fold serial broth
microdilutions in 96-well plates in the presence or absence of
20 µg/mL of the eﬄux pump inhibitor phenylalanine-arginine β-
naphthylamide (PAβN) dihydrochloride (Sigma, St. Louis, USA).
Both unexposed parental strains and survivors showing stable
profiles with 4- to 8-fold increases in MICs were chosen for
further study. These selections were performed in triplicate and
experiments were repeated twice. If the MIC values decreased
4-fold or greater upon exposure to PAβN, eﬄux activity was
judged as high. In order to explore the possibility of cross
heteroresistance between unrelated antibiotics, susceptibility to
ciprofloxacin was also determined for heteroresistant colonies.
Accumulation of Tigecycline
Eﬄux activity of selected isolates was further evaluated
by determining the accumulation of tigecycline (inversely
proportional to eﬄux activity) according to the method
of ciprofloxacin accumulation (Sun et al., 2011). A liquid
chromatography assay was used to determine tigecycline
concentrations (Li et al., 2004). Differences in drug accumulation
at steady-state between randomly selected survivors and the
parental strain14028 (see results) were analyzed for statistical
significance using a two-tailed Student’s t-test. P< 0.05 was taken
as significant. Data shown aremeans of at least three independent
technical replicates (±SEM).
Quantitative Real-Time Pcr (qRT-PCR)
Analysis
The expression levels of marA, soxS, rob, and ramA regulator
genes and eﬄux components acrA, acrB, tolC, and oqxB
were assessed using qRT-PCR. Bacteria were grown to mid-
logarithmic phase and total RNA was extracted by using Trizol
reagent (Invitrogen, Carlsbad, CA). RNA yield and quality were
measured using a BioPhotometer plus instrument (Eppendorf,
Shanghai, China) and cDNA was synthesized from 0.5mg RNA
templates using a PrimeScript RT reagent Kit with gDNA Eraser
(Perfect Real Time) according to the manufacturer’s instructions
(TaKaRa, Dalian, China). qRT-PCR was carried out in an IQ5
thermal cycler (Bio-Rad, Hercules, CA) using SYBR R© Premix
Ex Taq (TaKaRa, Dalian, China). Primers are listed in the
Table S1. PCR conditions were as previously described(Abouzeed
et al., 2008; Kehrenberg et al., 2009; Zheng et al., 2009; Wong
et al., 2015). qRT–PCR experiments were performed in triplicate
using different RNA preparations for confirmation of the results.
The 2−11Ct method was used to calculate fold changes of
mRNA levels of target genes in selected survivors compared
with those observed in their respective parental strains (strains
14028, 14028/pHXY0908, and 14028/1p52). Expression levels
of all pump genes and pump regulators of parental strains
were designated to be 1. Only genes whose ratios were ≥2-
fold changes (either increased or decreased) were considered
statistically significant (Zheng et al., 2011).
DNA Sequence Analysis
To detect mutations in regions known to be involved in the
regulation of the eﬄux pump AcrAB-TolC, we amplified acrR,
soxR, marR, and ramR using primers and PCR conditions as
described previously (Olliver et al., 2004; Abouzeed et al., 2008).
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The PCR products were sent for DNA sequencing (company
and location). Sequences were compared with those from the
GenBank nucleotide database using the BLAST (Basic Local
Alignment Search Tool) algorithm (http://www.ncbi.nlm.nih.
gov/BLAST).
Plasmid Curing
To confirm the role of genes on the plasmid in tigecycline
heteroresistance, the cure of plasmid from a heteroresistant
isolate 14028/p#52 was conducted using sodium dodecyl sulfate
(SDS) as previously described (Akiyama et al., 2013). Briefly, an
overnight culture was diluted 100-fold in LB broth containing
10% SDS and then was incubated overnight at 42◦C. Bacterial
suspensions were streaked onto LB agar and individual colonies
were replica plated onto LB agar plates with or without
olaquindox (50 µg/mL). To verify the plasmid loss, PCR
amplification of the oqxB gene was performed for those colonies
that did not grow in olaquindox. The cured strain was named
14028/1p52. Heteroresistance to tigecycline of 14028/1p52 were
characterized and experiments were conducted as those used for
14028 and 14028/pHXY0908.
RESULTS
Acquiring an oqxAB-Bearing Plasmid
pHXY0908 makes Salmonella Enterica
Serovar Typhimurium Heteroresistant to
Tigecycline
The tigecycline MICs of the 14028, 14028/pHXY0908, and
14028/1p52 strains did not show significant differences and
were 0.5, 1, and 1 µg/mL, respectively. However, in strain
14028/pHXY0908, the PAP curve indicated the presence
of subpopulations with high-level resistance to tigecycline
at frequencies ranging from 10−5 to 10−8. Conversely,
subpopulations of 14028 and 14028/1p52 did not show
this extent of resistance and grew to less than four times their
MICs (Figure 1).
pHXY0908 Increases the Frequency of
Emergence of Strains with Reduced
Susceptibility
Luria-Delbrück fluctuation analysis indicated that bacteria
survived the selection process at relatively low frequencies
(≤10−7; Tables S2–S4). The strain 14028/pHXY0908 survivors
were cells that were present in the starting bacterial culture
indicating no selection occurred during this experiment. MIC
of isolates directly picked from drug-containing plates showed
widely distributed values (Figure 1S).
We re-tested susceptibility of these colonies by subculturing
in antibiotic-free medium. A substantial number of these strains
returned to tigecycline susceptibility (Figure 1S). Only 4 (4/43),
21 (21/55), and 9 (9/36) isolates of 14028, 14028/pHXY0908, and
14028/1p52 respectively, showed stable profiles with 4 to 8-fold
MIC increases.
The frequency of emergence of these isolates was significantly
higher in strain 14028/pHXY0908 than in either 14028 or
FIGURE 1 | Susceptibility of S. Typhimurium14028, 14028/pHXY0908
and 14028/∆p52 to tigecycline as demonstrated by population
analysis. The x axis indicates the tigecycline concentration in micrograms per
milliliter used to select supopulations with higher tigecycline-resistance levels,
and on the y axis, the frequency of bacterial cells is given as the logarithm to
the base 10 of cfu per milliliter.
14028/1p52 (P < 0.05). Ciprofloxacin susceptibility of 21
heteroresistant isolates of 14028/pHXY0908 were tested and
exhibited 4- to 8-fold increases in MICs (1–2 µg/mL for
heteroresistant isolates; 0.25 µg/mL for 14028/pHXY0908)
(detailed data not shown).
Tigecycline Susceptibility Was Reversed by
Adding Efflux Pump Inhibitor (PAβN)
As eﬄux pumps are implicated in tigecycline resistance in
Salmonella, we examined whether eﬄux pumps were also
associated with tigecycline heteroresistance. The addition of the
eﬄux pump inhibitor PAβN reduced MIC values 2- to 64-fold
(Table S5). This data indicated that eﬄux pumps are involved in
heteroresistance.
Less Accumulation of Tigecycline in
Strains with Reduced Susceptibility
Since the intracellular accumulation of drugs were inversely
proportional to eﬄux activity, we measured concentrations of
tigecycline in selected survivors and parental strain. Results
showed that the steady-state tigecycline concentrations in two
plasmid containing strains (14028/p#36 and 14028/p#52) were
2- and 3-fold less than the parental strain 14028 (P < 0.001).
Reduced tigecycline accumulation was also observed in 14028#2
(P < 0.05), 14028#3(P < 0.05), 14028/1p52#17 (P < 0.01), and
14028/1p52#18 (P < 0.05) (Figure 2).
Upregulation of Pump Genes and
Regulators in Strains with Reduced
Susceptibility
To further confirm that eﬄux pumps were responsible for the
reduced tigecycline susceptibility and accumulation, we selected
survivors and determined the relative mRNA levels of the eﬄux
pump genes acrB and oqxB. The levels of both genes in all strains
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FIGURE 2 | Accumulation of tigecycline in isolates relative to strain
14028. The data shown are the means of two biological replicates. *P < 0.05;
**P < 0.01; ***P < 0.001.
were 2- to 5-fold greater than controls. This trend was also seen
with the global regulator ramA. Interestingly, in two isolates the
increases were 28.5- and 77-fold (Figure 3 and Figure 2S). Up-
regulation of pump genes acrA, tolC, and pump regulator marA
were observed in all of tested isolates. Strain 14028/p#36 also
showed increased expression of soxS while rob expression was
similar to those of the parental strains.
Interestingly, curing the plasmid in 14028/p#52 decreased the
expression of acrA by −5.45- ± 0.70-fold and acrB by −3.47- ±
0.57-fold (data not shown) and decreased the tigecycline MIC to
1 µg/mL.
Mutations in ramR Gene Leads to
Overexpression of ramA and acrAB
To investigate causes of the increased expression of ramA and
acrAB, DNA sequencing of the regulatory regions was performed.
Analyzing of ramR gene detected a point mutation, ACC→CCC,
at position 52 leading to the amino acid substitution of
threonine for proline (T18P) in the resistant isolates 14028/p#36,
14028/p#52, 14028/1p52#17, and 14028/1p52#18 (Table 2). In
14028#2, a mutation at amino acid 39 of RamR (V39A) was
identified. An insertion of 1bp (A) located at nucleotide position
63 within the ramR gene was identified in 14028#3. This insertion
led to occurrence of a premature stop codon (R21Stop). All of
tested strains were confirmed to have wild type acrR, soxR, and
marR sequences.
DISCUSSION
Heteroresistance describes the coexistence of susceptible and
resistant isolates in an otherwise genetically identical population
(Hung et al., 2012). This study illustrates that heteroresistance
to tigecycline in S. Typhimurium harboring an oqxAB-
bearing multidrug resistance plasmid (Table 2). The increase in
resistant subpopulations was greatest in strain 14028/pHXY0908
compared to strains 14028 and 14028/1p52. It also exhibited
a heteroresistance profile while a homogeneous response to
tigecycline was observed in parental strain 14028. Interestingly,
although 14028/1p52 and 14028/pHXY0908 exhibited the same
susceptibility to tigecycline by the broth microdilution method,
subpopulations of 14028/1p52 were unable to survive at 4 ×
MIC, similar to 14028. This indicated that the oqxAB-bearing
plasmid is the reason for the heteroresistant phenotype of
14028/pHXY0908.
Subpopulations with high-level resistance to tigecycline
occurred at relatively low frequencies (10−5–10−8) and MIC-
values (1 µg/mL) were below the susceptibility breakpoint
(2 µg/mL). This indicates that the CLSI reference methods
for antimicrobial susceptibility testing using an inoculum of
5 × 105 CFU/mL would classify such heteroresistant isolates
as susceptible (Gomes et al., 2015). A similar assessment of
susceptibility levels were found in a previous study that identified
heterogeneous growth to carbapenems in K. pneumoniae
carbapenemase (KPC)-producing Enterobacteriaceae (Pournaras
et al., 2010). Accordingly, evaluating results of susceptibility
testing should include determination of heteroresistant isolates.
In the present study, a resistance profile was maintained in the
absence of selection stress in S. Typhimurium. The frequencies
of emergent isolates showing stable profiles (4- to 8-fold
increase in MIC) were significantly higher in 14028/pHXY0908
than in 14028 and 14028/1p52. Again, this suggests that
plasmid pHXY0908 facilitates the appearance of tigecycline-non-
susceptible isolates. Heteroresistant isolates of 14028/pHXY0908
also had a decreased susceptibility to ciprofloxacin. This
indicated the presence of a mechanism leading to cross-
heteroresistance to different antibiotic classes (Hornsey et al.,
2010).
Previous study has indicated that upregulation of the AcrAB
eﬄux pump upon exposure to ciprofloxacin caused cross-
resistance to tigecycline (Hornsey et al., 2010). This occurrence
is of great concern because of the greater probability to induce
cross-resistance to new antibiotics with the application of
empirical therapies. Overexpression of eﬄux pump can also
lead to tigecycline resistance in S. aureus and, furthermore,
that the acquisition of this resistance may be associated
with reduced susceptibility to vancomycin (Herrera et al.,
2016). After addition of PAβN, reduction of MIC values was
observed for all resistant isolates that indirectly proves that
eﬄux pump over-expression contributed to reduced tigecycline
susceptibility. Furthermore, we directly confirmed eﬄux activity
by determining the accumulation of intracellular of tigecycline.
Therefore, this was an effective mechanism for heteroresistance
or non-susceptibility in S. Typhimurium pertaining to activity of
tigecycline.
A recent study has been sought to elucidate the roles
of Salmonella multidrug eﬄux pumps and AcrAB regulators
in tigecycline resistance, and results obtained showed that
deletion of acrAB led to strains with significantly increased
susceptibility to tigecycline and plasmids carrying the acrAB
restored increased susceptibility of the acrAB -deleted mutant
(Horiyama et al., 2011). That study demonstrated that reduced
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FIGURE 3 | Comparison of relative expression levels of acrB (A), oqxB (B) and ramA (C) in isolates 14028#2, 14028#3, 14028/p#36, 14028/p#52,
14028/1p52#17 and 14028/1p52#18 compared with their respective parental strains 14028, 14028/pHXY0908 and 14028/1p52, and oqxB (B) in isolates
14028/p#36 and 14028/p#52 compared with 14028/pHXY0908. Expression level of acrB, oqxB, and ramA of parental strains were designated to be 1. *P < 0.01.
TABLE 2 | Characteristics of Salmonella strains identified in this study.
Strains Heteroresistancea MIC range
(µg/mL)b
Stability ratec
(%)
Inhibited by
PAβNd
Intracellular
accumulatione
Expression
level of acrB,
oqxB, ramAf
Nucleotide
Mutation (amino
acid change)g
14028 − 0.5–2 4/43 (9.30%) Yes *** ↑ T116C (V39A)g1
63insA1(R21Stop)g2
14028/pHXY0908 + 1–8 21/55 (38.18%) Yes * ↑ A52C (T18P)g3
14028/∆p52 − 1–8 9/36 (25%) Yes ** ↑ A52C (T18P)g3
a, +, heteroresistance to tigecycline, -, homogeneous response to tigecycline; b, MICs of isolates directly picked up from drug-containing plates in the performance of Luria-Delbrück
fluctuation analysis; c, frequencies of emergence of isolates showing stable profiles with 4 to 8-fold increases in MICs; d, restoration of tigecycline susceptibility by inhibition of the
pump with PAβN; e, intracellular accumulation of tigecycline of selected survivors compared with 14028, ***, maximum, **, medium, *, minimum; f, ↑, upregulation of acrB and ramA in
survivors compared with those observed in their respective parental strains 14028, 14028/pHXY0908 and 14028/∆p52, and of oqxB in 14028/p#36 and 14028/p#52; g, nucleotide
mutation and amino acid substitution in RamR, g1, mutation found in 14028#2, g2, mutation found in 14028#3, g3, mutation found in 14028/p#36, 14028/p#52, 14028/∆p52#17, and
14028/∆p52#18, ins, insertion.
susceptibility to tigecycline might develop as a result of
increased expression of eﬄux pump AcrAB in Salmonella
enterica (Horiyama et al., 2011). Up-regulation of AdeABC,
another resistance-nodulation-division eﬄux pump, has been
proved resulting in decreased susceptibility to tigecycline in A.
calcoaceticus–A. baumannii (Ruzin et al., 2007). In the present
study, overexpression of acrAB in 14028/p#36 and 14028/p#52
were observed indicating that an active eﬄux system was
closely associated with heteroresistance to tigecycline. Consistent
with the published data that AcrAB confers resistance to
tigecycline (Horiyama et al., 2011), upregulation of AcrAB
was also observed in 14028/1p52#17 and 14028/1p52#18. In
addition, overexpression of the oqxB gene in both heteroresistant
isolates indicated that eﬄux pump OqxAB might play a role
in mediating tigecycline heteroresistance in S. Typhimurium
strains.
Up-regulation of global regulators ramA, marA, and soxS,
which activate the AcrAB eﬄux pump, were also observed
in isolates tested individually or as a group. Additionally,
in strains14028/p#36, 14028/p#52, 14028/1p52#17, and
14028/1p52#18 we found an amino acid change (T18P) in
ramR, which has been reported to play a role in the upregulation
of RamA and AcrAB (Abouzeed et al., 2008). This resulted in an
eﬄux-mediated MDR phenotype in S. Typhimurium.
Overexpression of ramA and inactivation of ramR involved
in AcrAB-dependent tigecycline resistance in Salmonella have
been suggested previously (Horiyama et al., 2011). In the current
study, these mutations in the ramR gene led to upregulation
of ramA resulting in tigecycline heteroresistance in our tested
isolates. In K. pneumoniae, oqxAB is downregulated by a
repressor (oqxR) in the presence of a positive level of control
via RamA, SoxS, and RarA (Veleba et al., 2012; Jiménez-
Castellanos et al., 2016). Loss of OqxR repressor function was
observed from the plasmid-borne oqxAB gene (Wong et al.,
2015). Thus, ramA overexpression seemed to upregulate the
oqxAB eﬄux pump in strains 14028/p#36 and 14028/p#52.
However, further work is necessary to explore whether RamA
can control the expression of the plasmid-encoded oqxAB gene
or whether RamA-mediated eﬄux pump overexpression can
increase plasmid-mediated resistance (Jiménez-Castellanos et al.,
2016).
Interestingly, when we cured the oqxAB-bearing plasmid from
a heteroresistant isolate (14028/p#52), restoration of tigecycline
susceptibility and downregulation of pump genes acrA and
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acrB were observed (data not shown). After we have test the
susceptibility of a cured strain in which the plasmid has been re-
introduced and the MIC was 8 µg/mL, indicating that approach
used for curing the plasmid would not affect the susceptibility
to tigecycline (data not shown). Thus, we hypothesized that in
addition to the global transcriptional regulator RamA, genes on
the plasmid might be also involved in the regulation of AcrAB-
TolC, contributing to tigecycline heteroresistance. Deciphering
potential mechanisms by which the oqxAB-bearing plasmid
participates in the regulation of AcrAB-TolC pump are under the
investigation in our laboratory.
It remains controversial whether heteroresistance is directly
linked to treatment failure (Moore et al., 2003; Falagas et al., 2008;
Deresinski, 2009; Lee et al., 2011) even though there is clinical
evidence that tigecycline monotherapy is associated with a high
mortality rate. Results obtained in the present study suggested
that the rapid induction of eﬄux pumps AcrAB-TolC and
OqxAB upon a single exposure to tigecycline in a heteroresistant
Salmonella strain in vitro might leads to tigecycline resistance.
Thus, heteroresistance should be taken into account when
tigecycline treatment is used to avoid inadvertently inducing
bacterial resistance. Appropriate detection methods are required
to guide therapeutic decision-making.
Heteroresistance to tigecycline has not been previously
reported so it is unclear whether there are other heteroresistant
species and what clinical significance this may have. Systematic
investigations on tigecycline heteroresistance in other pathogens
and the relationship between heteroresistance and treatment
failure are of practical importance.
In summary, the observations of present study suggested
that an epidemic oqxAB-bearing IncHI2-type plasmid might
engender a heteroresistant phenotype to S. Typhimurium
against tigecycline. This phenomenon was probably related to
overexpression of multidrug resistant eﬄux pumps AcrAB-TolC
and OqxAB.
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